<DOC>
	<DOCNO>NCT02107495</DOCNO>
	<brief_summary>To establish performance characteristic Samsung LABGEO IVD-A20 CHF Test intend use setting , compare test result A20 CHF Test result obtain FDA-cleared comparator assay .</brief_summary>
	<brief_title>Evaluation Samsung LABGEO IVD-A20 CHF Test Point-of-Care Setting</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>CHF Subjects : 21 year age great , clinically confirm CHF present clinical site sign , symptom and/or risk factor suggestive heart failure . Subjects Potentially confounding comorbidities : NonCHF subject 21 year age great , potentially confound comorbidities diabetes , renal insufficiency , hypertension chronic obstructive pulmonary disease ( COPD ) Healthy Subjects : apparently healthy subject great 45 year age , prior history cardiacrelated disease . Apparently healthy subject history MI , CHF cardiacrelated disease ; Subjects acute decompensated heart failure currently nesiritide therapy ; Subjects participate another experimental drug , biologic , invasive device study within 30 day prior sign inform consent study , enrol concurrently investigative study ; Subjects unable refuse provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>CHF</keyword>
</DOC>